ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 119 filers reported holding ORAMED PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $51,361 | -11.6% | 19,679 | +21.2% | 0.00% | – |
| Q2 2023 | $58,133 | +47.8% | 16,239 | -10.1% | 0.00% | – |
| Q1 2023 | $39,332 | -85.4% | 18,056 | -19.6% | 0.00% | -100.0% |
| Q4 2022 | $270,000 | +67.7% | 22,459 | -9.1% | 0.00% | – |
| Q3 2022 | $161,000 | +83.0% | 24,701 | +28.6% | 0.00% | – |
| Q2 2022 | $88,000 | -35.8% | 19,203 | +17.4% | 0.00% | – |
| Q1 2022 | $137,000 | -63.5% | 16,354 | -37.7% | 0.00% | -100.0% |
| Q4 2021 | $375,000 | -2.8% | 26,267 | +49.5% | 0.00% | 0.0% |
| Q3 2021 | $386,000 | +282.2% | 17,570 | +131.5% | 0.00% | – |
| Q2 2021 | $101,000 | +110.4% | 7,588 | +60.6% | 0.00% | – |
| Q1 2021 | $48,000 | +1100.0% | 4,725 | +372.5% | 0.00% | – |
| Q4 2020 | $4,000 | +33.3% | 1,000 | 0.0% | 0.00% | – |
| Q1 2020 | $3,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MORGAN JESS S & CO INC | 576,317 | $1,504,000 | 1.50% |
| Phoenix Holdings Ltd. | 197,763 | $483,000 | 0.02% |
| Frontier Wealth Management LLC | 71,900 | $188,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 19,659 | $51,000 | 0.01% |
| Rossmore Private Capital | 15,061 | $39,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 98,486 | $255,000 | 0.01% |
| Virtu Financial LLC | 10,450 | $27,000 | 0.01% |
| BOURGEON CAPITAL MANAGEMENT LLC | 5,627 | $15,000 | 0.01% |
| Sterling Investment Advisors, Ltd. | 3,150 | $8,000 | 0.00% |
| Qube Research & Technologies Ltd | 75,395 | $197,000 | 0.00% |